dc.contributor | Universidade de Brasília (UnB) | |
dc.contributor | Universidade Estadual Paulista (Unesp) | |
dc.date.accessioned | 2014-05-20T13:24:27Z | |
dc.date.available | 2014-05-20T13:24:27Z | |
dc.date.created | 2014-05-20T13:24:27Z | |
dc.date.issued | 2004-07-01 | |
dc.identifier | Current Drug Targets. Hilversum: Bentham Science Publ Ltd, v. 5, n. 5, p. 449-455, 2004. | |
dc.identifier | 1389-4501 | |
dc.identifier | http://hdl.handle.net/11449/7585 | |
dc.identifier | 10.2174/1389450043345407 | |
dc.identifier | WOS:000221917500006 | |
dc.description.abstract | Drug delivery systems are essential components of drugs controlled release. In the last decades, several drug delivery technologies have emerged including capsules, liposomes. microparticles, nanoparticles, and polymers. These components must be biocompatible, biodegradable, and display a desired biodistribution providing a long-term availability of the therapeutic at specific target over time. | |
dc.language | eng | |
dc.publisher | Bentham Science Publ Ltd | |
dc.relation | Current Drug Targets | |
dc.relation | 3.112 | |
dc.relation | 0,906 | |
dc.rights | Acesso restrito | |
dc.source | Web of Science | |
dc.subject | drug design | |
dc.subject | microtechnology | |
dc.subject | nanotechnology | |
dc.subject | nanospheres | |
dc.subject | nanocapsules | |
dc.subject | antibody-based drug delivery | |
dc.title | Drug delivery systems: Past, present, and future | |
dc.type | Otros | |